Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Naloxone on Hydromorphone PK
NCT02133820Phase 1Completed
- Sponsor
- Mundipharma
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydromorphone and naloxone in pain (4 arms), sponsored by Mundipharma. Primary endpoints: Area Under the Curve at 32 hours and Maximum Plasma Concentration at 32 hours. Started Apr 2014; status: completed.
02
Drugs
hydromorphonenaloxone
03
Conditions
pain
Beyond the preview
Go deeper on NCT02133820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133820.